Table of Contents 1 mRNA Vaccines & Therapeutics Market Overview 1.1 Product Overview and Scope of mRNA Vaccines & Therapeutics 1.2 mRNA Vaccines & Therapeutics Segment by Type 1.2.1 Global mRNA Vaccines & Therapeutics Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 Standardization Of Cancer Treatment MRNA Vaccine 1.2.3 Individualized Cancer Treatment MRNA Vaccine 1.2.4 Infectious Disease Treatment MRNA Vaccine 1.2.5 Infection Prevention MRNA Vaccine 1.3 mRNA Vaccines & Therapeutics Segment by Application 1.3.1 mRNA Vaccines & Therapeutics Sales Comparison by Application: 2020 VS 2026 1.3.2 Infectious Disease 1.3.3 Cancer 1.3.4 Other 1.4 Global mRNA Vaccines & Therapeutics Market Size Estimates and Forecasts 1.4.1 Global mRNA Vaccines & Therapeutics Revenue 2015-2026 1.4.2 Global mRNA Vaccines & Therapeutics Sales 2015-2026 1.4.3 mRNA Vaccines & Therapeutics Market Size by Region: 2020 Versus 2026 2 Global mRNA Vaccines & Therapeutics Market Competition by Manufacturers 2.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Manufacturers (2015-2020) 2.2 Global mRNA Vaccines & Therapeutics Revenue Share by Manufacturers (2015-2020) 2.3 Global mRNA Vaccines & Therapeutics Average Price by Manufacturers (2015-2020) 2.4 Manufacturers mRNA Vaccines & Therapeutics Manufacturing Sites, Area Served, Product Type 2.5 mRNA Vaccines & Therapeutics Market Competitive Situation and Trends 2.5.1 mRNA Vaccines & Therapeutics Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key mRNA Vaccines & Therapeutics Players (Opinion Leaders) 3 mRNA Vaccines & Therapeutics Retrospective Market Scenario by Region 3.1 Global mRNA Vaccines & Therapeutics Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global mRNA Vaccines & Therapeutics Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America mRNA Vaccines & Therapeutics Market Facts & Figures by Country 3.3.1 North America mRNA Vaccines & Therapeutics Sales by Country 3.3.2 North America mRNA Vaccines & Therapeutics Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe mRNA Vaccines & Therapeutics Market Facts & Figures by Country 3.4.1 Europe mRNA Vaccines & Therapeutics Sales by Country 3.4.2 Europe mRNA Vaccines & Therapeutics Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific mRNA Vaccines & Therapeutics Market Facts & Figures by Region 3.5.1 Asia Pacific mRNA Vaccines & Therapeutics Sales by Region 3.5.2 Asia Pacific mRNA Vaccines & Therapeutics Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America mRNA Vaccines & Therapeutics Market Facts & Figures by Country 3.6.1 Latin America mRNA Vaccines & Therapeutics Sales by Country 3.6.2 Latin America mRNA Vaccines & Therapeutics Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa mRNA Vaccines & Therapeutics Market Facts & Figures by Country 3.7.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales by Country 3.7.2 Middle East and Africa mRNA Vaccines & Therapeutics Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global mRNA Vaccines & Therapeutics Historic Market Analysis by Type 4.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2015-2020) 4.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2015-2020) 4.3 Global mRNA Vaccines & Therapeutics Price Market Share by Type (2015-2020) 4.4 Global mRNA Vaccines & Therapeutics Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global mRNA Vaccines & Therapeutics Historic Market Analysis by Application 5.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2015-2020) 5.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2015-2020) 5.3 Global mRNA Vaccines & Therapeutics Price by Application (2015-2020) 6 Company Profiles and Key Figures in mRNA Vaccines & Therapeutics Business 6.1 Moderna Therapeutics 6.1.1 Corporation Information 6.1.2 Moderna Therapeutics Description, Business Overview and Total Revenue 6.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Moderna Therapeutics Products Offered 6.1.5 Moderna Therapeutics Recent Development 6.2 CureVac 6.2.1 CureVac mRNA Vaccines & Therapeutics Production Sites and Area Served 6.2.2 CureVac Description, Business Overview and Total Revenue 6.2.3 CureVac mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2015-2020) 6.2.4 CureVac Products Offered 6.2.5 CureVac Recent Development 6.3 Translate Bio 6.3.1 Translate Bio mRNA Vaccines & Therapeutics Production Sites and Area Served 6.3.2 Translate Bio Description, Business Overview and Total Revenue 6.3.3 Translate Bio mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2015-2020) 6.3.4 Translate Bio Products Offered 6.3.5 Translate Bio Recent Development 6.4 BioNTech 6.4.1 BioNTech mRNA Vaccines & Therapeutics Production Sites and Area Served 6.4.2 BioNTech Description, Business Overview and Total Revenue 6.4.3 BioNTech mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2015-2020) 6.4.4 BioNTech Products Offered 6.4.5 BioNTech Recent Development 6.5 Sangamo Therapeutics 6.5.1 Sangamo Therapeutics mRNA Vaccines & Therapeutics Production Sites and Area Served 6.5.2 Sangamo Therapeutics Description, Business Overview and Total Revenue 6.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2015-2020) 6.5.4 Sangamo Therapeutics Products Offered 6.5.5 Sangamo Therapeutics Recent Development 6.6 Argos Therapeutics 6.6.1 Argos Therapeutics mRNA Vaccines & Therapeutics Production Sites and Area Served 6.6.2 Argos Therapeutics Description, Business Overview and Total Revenue 6.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2015-2020) 6.6.4 Argos Therapeutics Products Offered 6.6.5 Argos Therapeutics Recent Development 6.7 In-Cell-Art 6.6.1 In-Cell-Art mRNA Vaccines & Therapeutics Production Sites and Area Served 6.6.2 In-Cell-Art Description, Business Overview and Total Revenue 6.6.3 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2015-2020) 6.4.4 In-Cell-Art Products Offered 6.7.5 In-Cell-Art Recent Development 6.8 eTheRNA 6.8.1 eTheRNA mRNA Vaccines & Therapeutics Production Sites and Area Served 6.8.2 eTheRNA Description, Business Overview and Total Revenue 6.8.3 eTheRNA mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2015-2020) 6.8.4 eTheRNA Products Offered 6.8.5 eTheRNA Recent Development 6.9 Ethris 6.9.1 Ethris mRNA Vaccines & Therapeutics Production Sites and Area Served 6.9.2 Ethris Description, Business Overview and Total Revenue 6.9.3 Ethris mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2015-2020) 6.9.4 Ethris Products Offered 6.9.5 Ethris Recent Development 6.10 Tiba Biotechnology 6.10.1 Tiba Biotechnology mRNA Vaccines & Therapeutics Production Sites and Area Served 6.10.2 Tiba Biotechnology Description, Business Overview and Total Revenue 6.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2015-2020) 6.10.4 Tiba Biotechnology Products Offered 6.10.5 Tiba Biotechnology Recent Development 7 mRNA Vaccines & Therapeutics Manufacturing Cost Analysis 7.1 mRNA Vaccines & Therapeutics Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of mRNA Vaccines & Therapeutics 7.4 mRNA Vaccines & Therapeutics Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 mRNA Vaccines & Therapeutics Distributors List 8.3 mRNA Vaccines & Therapeutics Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global mRNA Vaccines & Therapeutics Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of mRNA Vaccines & Therapeutics by Type (2021-2026) 10.1.2 Global Forecasted Revenue of mRNA Vaccines & Therapeutics by Type (2021-2026) 10.2 mRNA Vaccines & Therapeutics Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of mRNA Vaccines & Therapeutics by Application (2021-2026) 10.2.2 Global Forecasted Revenue of mRNA Vaccines & Therapeutics by Application (2021-2026) 10.3 mRNA Vaccines & Therapeutics Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of mRNA Vaccines & Therapeutics by Region (2021-2026) 10.3.2 Global Forecasted Revenue of mRNA Vaccines & Therapeutics by Region (2021-2026) 10.4 North America mRNA Vaccines & Therapeutics Estimates and Projections (2021-2026) 10.5 Europe mRNA Vaccines & Therapeutics Estimates and Projections (2021-2026) 10.6 Asia Pacific mRNA Vaccines & Therapeutics Estimates and Projections (2021-2026) 10.7 Latin America mRNA Vaccines & Therapeutics Estimates and Projections (2021-2026) 10.8 Middle East and Africa mRNA Vaccines & Therapeutics Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global mRNA Vaccines & Therapeutics Sales (K Units) Growth Rate Comparison by Type (2015-2026) Table 2. Global mRNA Vaccines & Therapeutics Sales (K Units) Comparison by Application: 2020 VS 2026 Table 3. Global mRNA Vaccines & Therapeutics Market Size by Type (K Units) (US$ Million) (2020 VS 2026) Table 4. Global Key mRNA Vaccines & Therapeutics Manufacturers Covered in This Study Table 5. Global mRNA Vaccines & Therapeutics Sales (K Units) by Manufacturers (2015-2020) Table 6. Global mRNA Vaccines & Therapeutics Sales Share by Manufacturers (2015-2020) Table 7. Global mRNA Vaccines & Therapeutics Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global mRNA Vaccines & Therapeutics Revenue Share by Manufacturers (2015-2020) Table 9. Global Market mRNA Vaccines & Therapeutics Average Price (USD/Unit) of Key Manufacturers (2015-2020) Table 10. Manufacturers mRNA Vaccines & Therapeutics Sales Sites and Area Served Table 11. Manufacturers mRNA Vaccines & Therapeutics Product Types Table 12. Global mRNA Vaccines & Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global mRNA Vaccines & Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in mRNA Vaccines & Therapeutics as of 2019) Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key mRNA Vaccines & Therapeutics Players Table 16. Global mRNA Vaccines & Therapeutics Sales (K Units) by Region (2015-2020) Table 17. Global mRNA Vaccines & Therapeutics Sales Market Share by Region (2015-2020) Table 18. Global mRNA Vaccines & Therapeutics Revenue (Million US$) by Region (2015-2020) Table 19. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region (2015-2020) Table 20. North America mRNA Vaccines & Therapeutics Sales by Country (2015-2020) (K Units) Table 21. North America mRNA Vaccines & Therapeutics Sales Market Share by Country (2015-2020) Table 22. North America mRNA Vaccines & Therapeutics Revenue by Country (2015-2020) (US$ Million) Table 23. North America mRNA Vaccines & Therapeutics Revenue Market Share by Country (2015-2020) Table 24. Europe mRNA Vaccines & Therapeutics Sales by Country (2015-2020) (K Units) Table 25. Europe mRNA Vaccines & Therapeutics Sales Market Share by Country (2015-2020) Table 26. Europe mRNA Vaccines & Therapeutics Revenue by Country (2015-2020) (US$ Million) Table 27. Europe mRNA Vaccines & Therapeutics Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific mRNA Vaccines & Therapeutics Sales by Region (2015-2020) (K Units) Table 29. Asia Pacific mRNA Vaccines & Therapeutics Sales Market Share by Region (2015-2020) Table 30. Asia Pacific mRNA Vaccines & Therapeutics Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific mRNA Vaccines & Therapeutics Revenue Market Share by Region (2015-2020) Table 32. Latin America mRNA Vaccines & Therapeutics Sales by Country (2015-2020) (K Units) Table 33. Latin America mRNA Vaccines & Therapeutics Sales Market Share by Country (2015-2020) Table 34. Latin America mRNA Vaccines & Therapeutics Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America mRNA Vaccines & Therapeutics Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa mRNA Vaccines & Therapeutics Sales by Country (2015-2020) (K Units) Table 37. Middle East and Africa mRNA Vaccines & Therapeutics Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa mRNA Vaccines & Therapeutics Revenue Market Share by Country (2015-2020) Table 40. Global mRNA Vaccines & Therapeutics Sales (K Units) by Type (2015-2020) Table 41. Global mRNA Vaccines & Therapeutics Sales Share by Type (2015-2020) Table 42. Global mRNA Vaccines & Therapeutics Revenue (Million US$) by Type (2015-2020) Table 43. Global mRNA Vaccines & Therapeutics Revenue Share by Type (2015-2020) Table 44. Global mRNA Vaccines & Therapeutics Price (USD/Unit) by Type (2015-2020) Table 45. Global mRNA Vaccines & Therapeutics Sales (K Units) by Application (2015-2020) Table 46. Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2015-2020) Table 47. Global mRNA Vaccines & Therapeutics Sales Growth Rate by Application (2015-2020) Table 48. Moderna Therapeutics mRNA Vaccines & Therapeutics Corporation Information Table 49. Moderna Therapeutics Description and Business Overview Table 50. Moderna Therapeutics mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 51. Moderna Therapeutics Main Product Table 52. Moderna Therapeutics Recent Development Table 53. CureVac mRNA Vaccines & Therapeutics Corporation Information Table 54. CureVac Corporation Information Table 55. CureVac mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 56. CureVac Main Product Table 57. CureVac Recent Development Table 58. Translate Bio mRNA Vaccines & Therapeutics Corporation Information Table 59. Translate Bio Corporation Information Table 60. Translate Bio mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 61. Translate Bio Main Product Table 62. Translate Bio Recent Development Table 63. BioNTech mRNA Vaccines & Therapeutics Corporation Information Table 64. BioNTech Corporation Information Table 65. BioNTech mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 66. BioNTech Main Product Table 67. BioNTech Recent Development Table 68. Sangamo Therapeutics mRNA Vaccines & Therapeutics Corporation Information Table 69. Sangamo Therapeutics Corporation Information Table 70. Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 71. Sangamo Therapeutics Main Product Table 72. Sangamo Therapeutics Recent Development Table 73. Argos Therapeutics mRNA Vaccines & Therapeutics Corporation Information Table 74. Argos Therapeutics Corporation Information Table 75. Argos Therapeutics mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 76. Argos Therapeutics Main Product Table 77. Argos Therapeutics Recent Development Table 78. In-Cell-Art mRNA Vaccines & Therapeutics Corporation Information Table 79. In-Cell-Art Corporation Information Table 80. In-Cell-Art mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 81. In-Cell-Art Main Product Table 82. In-Cell-Art Recent Development Table 83. eTheRNA mRNA Vaccines & Therapeutics Corporation Information Table 84. eTheRNA Corporation Information Table 85. eTheRNA mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 86. eTheRNA Main Product Table 87. eTheRNA Recent Development Table 88. Ethris mRNA Vaccines & Therapeutics Corporation Information Table 89. Ethris Corporation Information Table 90. Ethris mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 91. Ethris Main Product Table 92. Ethris Recent Development Table 93. Tiba Biotechnology mRNA Vaccines & Therapeutics Corporation Information Table 94. Tiba Biotechnology Corporation Information Table 95. Tiba Biotechnology mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 96. Tiba Biotechnology Main Product Table 97. Tiba Biotechnology Recent Development Table 98. Sales Base and Market Concentration Rate of Raw Material Table 99. Key Suppliers of Raw Materials Table 100. mRNA Vaccines & Therapeutics Distributors List Table 101. mRNA Vaccines & Therapeutics Customers List Table 102. Market Key Trends Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 104. Key Challenges Table 105. Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Type (2021-2026) Table 106. Global mRNA Vaccines & Therapeutics Sales Market Share Forecast by Type (2021-2026) Table 107. Global mRNA Vaccines & Therapeutics Revenue (Million US$) Forecast by Type (2021-2026) Table 108. Global mRNA Vaccines & Therapeutics Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 109. Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Application (2021-2026) Table 110. Global mRNA Vaccines & Therapeutics Revenue (Million US$) Forecast by Application (2021-2026) Table 111. Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Region (2021-2026) Table 112. Global mRNA Vaccines & Therapeutics Sales Market Share Forecast by Region (2021-2026) Table 113. Global mRNA Vaccines & Therapeutics Revenue Forecast by Region (2021-2026) (US$ Million) Table 114. Global mRNA Vaccines & Therapeutics Revenue Market Share Forecast by Region (2021-2026) Table 115. Research Programs/Design for This Report Table 116. Key Data Information from Secondary Sources Table 117. Key Data Information from Primary Sources List of Figures Figure 1. Picture of mRNA Vaccines & Therapeutics Figure 2. Global mRNA Vaccines & Therapeutics Sales Market Share by Type: 2020 VS 2026 Figure 3. Standardization Of Cancer Treatment MRNA Vaccine Product Picture Figure 4. Individualized Cancer Treatment MRNA Vaccine Product Picture Figure 5. Infectious Disease Treatment MRNA Vaccine Product Picture Figure 6. Infection Prevention MRNA Vaccine Product Picture Figure 7. Global mRNA Vaccines & Therapeutics Consumption Market Share by Application: 2020 VS 2026 Figure 8. Infectious Disease Figure 9. Cancer Figure 10. Other Figure 11. Global mRNA Vaccines & Therapeutics Market Size 2015-2026 (US$ Million) Figure 12. Global mRNA Vaccines & Therapeutics Sales Capacity (K Units) (2015-2026) Figure 13. Global mRNA Vaccines & Therapeutics Market Size Market Share by Region: 2020 Versus 2026 Figure 14. mRNA Vaccines & Therapeutics Sales Share by Manufacturers in 2020 Figure 15. Global mRNA Vaccines & Therapeutics Revenue Share by Manufacturers in 2019 Figure 16. The Global 5 and 10 Largest Players: Market Share by mRNA Vaccines & Therapeutics Revenue in 2019 Figure 17. mRNA Vaccines & Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 18. Global mRNA Vaccines & Therapeutics Sales Market Share by Region (2015-2020) Figure 19. Global mRNA Vaccines & Therapeutics Sales Market Share by Region in 2019 Figure 20. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region (2015-2020) Figure 21. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region in 2019 Figure 22. North America mRNA Vaccines & Therapeutics Sales Market Share by Country in 2019 Figure 23. North America mRNA Vaccines & Therapeutics Revenue Market Share by Country in 2019 Figure 24. U.S. mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units) Figure 25. U.S. mRNA Vaccines & Therapeutics Revenue Growth Rate (2015-2020) (US$ Million) Figure 26. Canada mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units) Figure 27. Canada mRNA Vaccines & Therapeutics Revenue Growth Rate (2015-2020) (US$ Million) Figure 28. Europe mRNA Vaccines & Therapeutics Sales Market Share by Country in 2019 Figure 29. Europe mRNA Vaccines & Therapeutics Revenue Market Share by Country in 2019 Figure 30. Germany mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units) Figure 31. Germany mRNA Vaccines & Therapeutics Revenue Growth Rate (2015-2020) (US$ Million) Figure 32. France mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units) Figure 33. France mRNA Vaccines & Therapeutics Revenue Growth Rate (2015-2020) (US$ Million) Figure 34. U.K. mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units) Figure 35. U.K. mRNA Vaccines & Therapeutics Revenue Growth Rate (2015-2020) (US$ Million) Figure 36. Italy mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units) Figure 37. Italy mRNA Vaccines & Therapeutics Revenue Growth Rate (2015-2020) (US$ Million) Figure 38. Russia mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units) Figure 39. Russia mRNA Vaccines & Therapeutics Revenue Growth Rate (2015-2020) (US$ Million) Figure 40. Asia Pacific mRNA Vaccines & Therapeutics Sales Market Share by Region in 2019 Figure 41. Asia Pacific mRNA Vaccines & Therapeutics Revenue Market Share by Region in 2019 Figure 42. China mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units) Figure 43. China mRNA Vaccines & Therapeutics Revenue Growth Rate (2015-2020) (US$ Million) Figure 44. Japan mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units) Figure 45. Japan mRNA Vaccines & Therapeutics Revenue Growth Rate (2015-2020) (US$ Million) Figure 46. South Korea mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units) Figure 47. South Korea mRNA Vaccines & Therapeutics Revenue Growth Rate (2015-2020) (US$ Million) Figure 48. India mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units) Figure 49. India mRNA Vaccines & Therapeutics Revenue Growth Rate (2015-2020) (US$ Million) Figure 50. Australia mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units) Figure 51. Australia mRNA Vaccines & Therapeutics Revenue Growth Rate (2015-2020) (US$ Million) Figure 52. Taiwan mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units) Figure 53. Taiwan mRNA Vaccines & Therapeutics Revenue Growth Rate (2015-2020) (US$ Million) Figure 54. Indonesia mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units) Figure 55. Indonesia mRNA Vaccines & Therapeutics Revenue Growth Rate (2015-2020) (US$ Million) Figure 56. Thailand mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units) Figure 57. Thailand mRNA Vaccines & Therapeutics Revenue Growth Rate (2015-2020) (US$ Million) Figure 58. Malaysia mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units) Figure 59. Malaysia mRNA Vaccines & Therapeutics Revenue Growth Rate (2015-2020) (US$ Million) Figure 60. Philippines mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units) Figure 61. Philippines mRNA Vaccines & Therapeutics Revenue Growth Rate (2015-2020) (US$ Million) Figure 62. Vietnam mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units) Figure 63. Vietnam mRNA Vaccines & Therapeutics Revenue Growth Rate (2015-2020) (US$ Million) Figure 64. Latin America mRNA Vaccines & Therapeutics Sales Market Share by Country in 2019 Figure 65. Latin America mRNA Vaccines & Therapeutics Revenue Market Share by Country in 2019 Figure 66. Mexico mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units) Figure 67. Mexico mRNA Vaccines & Therapeutics Revenue Growth Rate (2015-2020) (US$ Million) Figure 68. Brazil mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units) Figure 69. Brazil mRNA Vaccines & Therapeutics Revenue Growth Rate (2015-2020) (US$ Million) Figure 70. Argentina mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units) Figure 71. Argentina mRNA Vaccines & Therapeutics Revenue Growth Rate (2015-2020) (US$ Million) Figure 72. Middle East and Africa mRNA Vaccines & Therapeutics Sales Market Share by Country in 2019 Figure 73. Middle East and Africa mRNA Vaccines & Therapeutics Revenue Market Share by Country in 2019 Figure 74. Turkey mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units) Figure 75. Turkey mRNA Vaccines & Therapeutics Revenue Growth Rate (2015-2020) (US$ Million) Figure 76. Saudi Arabia mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units) Figure 77. Saudi Arabia mRNA Vaccines & Therapeutics Revenue Growth Rate (2015-2020) (US$ Million) Figure 78. U.A.E mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units) Figure 79. U.A.E mRNA Vaccines & Therapeutics Revenue Growth Rate (2015-2020) (US$ Million) Figure 80. Sales Market Share of mRNA Vaccines & Therapeutics by Type (2015-2020) Figure 81. Sales Market Share of mRNA Vaccines & Therapeutics by Type in 2019 Figure 82. Revenue Share of mRNA Vaccines & Therapeutics by Type (2015-2020) Figure 83. Revenue Market Share of mRNA Vaccines & Therapeutics by Type in 2019 Figure 84. Global mRNA Vaccines & Therapeutics Sales Growth by Type (2015-2020) (K Units) Figure 85. Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2015-2020) Figure 86. Global mRNA Vaccines & Therapeutics Sales Market Share by Application in 2019 Figure 87. Global Revenue Share of mRNA Vaccines & Therapeutics by Application (2015-2020) Figure 88. Global Revenue Share of mRNA Vaccines & Therapeutics by Application in 2020 Figure 89. Moderna Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. CureVac Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Translate Bio Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. BioNTech Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Sangamo Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. Argos Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. In-Cell-Art Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. eTheRNA Total Revenue (US$ Million): 2019 Compared with 2018 Figure 97. Ethris Total Revenue (US$ Million): 2019 Compared with 2018 Figure 98. Tiba Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018 Figure 99. Price Trend of Key Raw Materials Figure 100. Manufacturing Cost Structure of mRNA Vaccines & Therapeutics Figure 101. Manufacturing Process Analysis of mRNA Vaccines & Therapeutics Figure 102. mRNA Vaccines & Therapeutics Industrial Chain Analysis Figure 103. Channels of Distribution Figure 104. Distributors Profiles Figure 105. Porter's Five Forces Analysis Figure 106. North America mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 107. North America mRNA Vaccines & Therapeutics Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 108. Europe mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 109. Europe mRNA Vaccines & Therapeutics Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 110. Latin America mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 111. Latin America mRNA Vaccines & Therapeutics Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 112. Middle East and Africa mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 113. Middle East and Africa mRNA Vaccines & Therapeutics Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 114. Asia Pacific mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 115. Asia Pacific mRNA Vaccines & Therapeutics Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 116. Bottom-up and Top-down Approaches for This Report Figure 117. Data Triangulation Figure 118. Key Executives Interviewed

Moderna Therapeutics CureVac Translate Bio BioNTech Sangamo Therapeutics Argos Therapeutics In-Cell-Art eTheRNA Ethris Tiba Biotechnology